Clinical Consequences of Screening for Prostate Cancer: 15 Years Follow-up of a Randomised Controlled Trial in Sweden
- 31 December 2004
- journal article
- clinical trial
- Published by Elsevier in European Urology
- Vol. 46 (6) , 717-724
- https://doi.org/10.1016/j.eururo.2004.08.011
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interval carcinomas in the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Rotterdam.JNCI Journal of the National Cancer Institute, 2003
- Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer—A Prospective Study Based on Data from a Swedish Population-Based CohortEuropean Urology, 2003
- Validity of a Population-Based Cancer Register in Sweden An Assessment of Data Reproducibility in the South-East Region Prostate Cancer RegisterScandinavian Journal of Urology and Nephrology, 2003
- Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trialInternational Journal of Cancer, 2001
- The European Randomized Study of Screening for Prostate Cancer (ERSPC): An UpdateEuropean Urology, 1999
- The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer instituteCancer, 1995
- Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term FollowupJournal of Urology, 1993
- Costs and benefits of early detection of prostatic cancerHealth Policy, 1990
- Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population.BMJ, 1990
- Fine Needle Aspiration Biopsy of the Prostate Gland: A Study of 103 Cases With Histological FollowupJournal of Urology, 1986